New drug combo aims to tackle tough lymphoma
NCT ID NCT05222555
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a modified intravenous dosing schedule of tafasitamab combined with oral lenalidomide in 53 adults with relapsed or refractory diffuse large B-cell lymphoma who are not eligible for a stem cell transplant. The main goal is to evaluate safety and how the drug moves through the body, with a secondary focus on tumor response. It is an early-phase, open-label trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tafasitamab (a targeted antibody) and lenalidomide (an immune-modulating drug)
- What this could lead to
- If successful, this could offer a new treatment option for people with relapsed or refractory diffuse large B-cell lymphoma who cannot have a stem cell transplant.
- What could go wrong
- This is an early-phase trial with only 53 participants, so results may not apply broadly. Side effects from the drug combination could be significant, and the modified dosing may not improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda
Milan, Lombardy, 20162, Italy
-
ASST di Monza - Azienda Ospedaliera San Gerardo
Monza, Monza E Brianza, 20900, Italy
-
Asan Medical Center - PPDS
Seoul, 5505, South Korea
-
Azienda Ospedaliera di Perugia
Perugia, Umbria, 6122, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, Tuscany, 56127, Italy
-
CHU Nantes
Nantes, Loire-Atlantique, 44000, France
-
CHU de Poitiers
Poitiers, Vienne, 86021, France
-
Centre Hospitalier Le Mans
Le Mans, Sarthe, 72000, France
-
Centre Hospitalier Universitaire Grenoble Alpes - Hopital Albert Michallon
Grenoble, Isère, 38043, France
-
Centrum Medyczne Poznan - PRATIA - PPDS
Skórzewo, Greater Poland Voivodeship, 60-185, Poland
-
Chonbuk National University Hospital
Jeonju, 54907, South Korea
-
Complejo Asistencial Universitario de Salamanca - H. Clinico
Salamanca, 37007, Spain
-
Daegu Catholic University Medical Center
Daegu, 42472, South Korea
-
Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii
Wroclaw, Lower Silesian Voivodeship, 53-439, Poland
-
Dong-A University Medical Center
Busan, 49201, South Korea
-
Fakultni nemocnice Brno
Brno, 625 00, Czechia
-
Fakultni nemocnice Kralovske Vinohrady
Prague, 100 34, Czechia
-
Fakultni nemocnice Ostrava
Ostrava, 708 52, Czechia
-
Fakultni nemocnice v Motole
Prague, 150 06, Czechia
-
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Lombardy, 20122, Italy
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Lombardy, 27100, Italy
-
Fondazione del Piemonte per l'Oncologia (IRCCS)
Candiolo, Piedmont, 10060, Italy
-
Gachon University Gil Medical Center
Incheon, 21565, South Korea
-
Hadassah Medical Center - Hadassah Ein Kerem
Jerusalem, 91120, Israel
-
Hanyang University Medical Center
Seoul, 4763, South Korea
-
Hospital Son Llatzer
Palma de Mallorca, Balearic Islands, 7198, Spain
-
Hospital U. Infanta Leonor
Madrid, 28031, Spain
-
Hospital U. Quironsalud Madrid
Madrid, 28223, Spain
-
Hospital U. Ramon y Cajal
Madrid, 28034, Spain
-
Hospital U. Virgen del Rocio
Seville, 41013, Spain
-
Hospital Universitari La Fe
Valencia, 46026, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
ICO l'Hospitalet - Hospital Duran i Reynals
L'Hospitalet de Llobregat, 8907, Spain
-
Institut Catala d'Oncologia Girona
Girona, 17007, Spain
-
Klinikum Wels Grieskirchen
Wels, Upper Austria, 4600, Austria
-
Kosin University Gospel Hospital
Busan, 49267, South Korea
-
Lady Davis Carmel Medical Center
Haifa, 34362, Israel
-
MD Anderson Madrid
Madrid, 28033, Spain
-
Morristown Memorial Hospital
Morristown, New Jersey, 07960-6459, United States
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
Warsaw, Masovian Voivodeship, 02-781, Poland
-
Nasz Lekarz Osrodek Badan Klinicznych
Torun, 87-100, Poland
-
Ospedale Santa Maria Delle Croci
Ravenna, Emilia-Romagna, 48121, Italy
-
Pratia MCM Krakow
Krakow, Lesser Poland Voivodeship, 30-510, Poland
-
Pusan National University Hospital
Busan, 49241, South Korea
-
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, 31-501, Poland
-
SPZOZ MiSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie
Olsztyn, 10-228, Poland
-
Shamir Medical Center Assaf Harofeh
Be’er Ya‘aqov, 70300, Israel
-
Soroka University Medical Centre
Beersheba, Southern District, 84101, Israel
-
Szpital Wojewodzki w Opolu
Opole, Opole Voivodeship, 45-061, Poland
-
Szpitale Pomorskie Sp. z o. o.
Gdynia, 81-519, Poland
-
Texas Oncology-Baylor Charles A. Sammons Cancer Center - USOR
Dallas, Texas, 75246-2092, United States
-
The Catholic University of Korea, St. Vincent's Hospital
Suwon, Gyeonggido, 16247, South Korea
-
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, 7345, South Korea
-
UK St. Pölten
Sankt Pölten, Lower Austria, 3100, Austria
-
Ulsan University Hospital
Ulsan, 44033, South Korea
-
Universitatsklinikum Salzburg
Salzburg, 5020, Austria
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
Wroclaw, Lower Silesian Voivodeship, 50-367, Poland
-
Vista Oncology
Olympia, Washington, 98506, United States
-
Vseobecna Fakultni Nemocnice V Praze
Prague, 128 08, Czechia
-
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi
Lodz, 93-513, Poland
-
Yeungnam University Hospital
Daegu, 42415, South Korea
-
ZIV Medical Center
Safed, 13100, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can donor immune cells be engineered to fight blood cancer?
- Can a simple blood test spot lymphoma earlier?
- Can a Light-Based device spot dangerous infection risk without a blood draw?